-
13 June 2025 23:11:41
- Source: Sharecast

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION
Baronsmead Venture Trust plc
(the "Company")
LEI: 213800VQ1PQHOJXDDQ88
13 June 2025
Close of Offer to New Applications
The board of the Company (the "Board") announces that, on the basis of valid applications received, the BVT Offer is now closed to further subscriptions, and no further applications for shares under the BVT Offer will be accepted.
Therefore, as announced previously, the fourth allotment under the BVT Offer is expected to take place on or around 3 July 2025, which will be the final allotment under the BVT Offer.
The Board announced on 10 January 2025 that the Company, together with Baronsmead Second Venture Trust plc, had published a prospectus (the "Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise over-allotment facilities to raise up to a further £20 million in aggregate (the "Offers" and each the "BVT Offer" or "BSVT Offer"). Full details of the Offers are contained in the Prospectus.
Terms used in this announcement have the same meaning as defined in the Prospectus.
For further information please contact:
Baronsmead VCT Investor Relations
020 7382 0999
baronsmeadvcts@greshamhouse.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.